Characterizing a cyanobacterial bloom in western Lake Erie using satellite imagery and meteorological data

The distribution and intensity of a bloom of the toxic cyanobacterium, Microcystis aeruginosa, in western Lake Erie was characterized using a combination of satellite ocean-color imagery, field data, and meteorological observations. The bloom was first identified by satellite on 14 August 2008 and persisted for more than 2 months. The distribution and intensity of the bloom was estimated using a satellite algorithm that is sensitive to near-surface concentrations of M. aeruginosa. Increases in both area and intensity were most pronounced for wind stress less than 0.05 Pa. Area increased while intensity did not change for wind stresses of 0.05–0.1 Pa, and both decreased for wind stress greater than 0.1 Pa. The recovery in intensity at the surface after strong wind events indicated that high wind stress mixed the bloom through the water column and that it returned to the surface once mixing stopped. This interaction is consistent with the understanding of the buoyancy of these blooms. Cloud cover (reduced light) may have a weak influence on intensity during calm conditions. While water temperature remained greater than 15°C, the bloom intensified if there were calm conditions. For water temperature less than 15°C, the bloom subsided under similar conditions. As a result, wind stress needs to be considered when interpreting satellite imagery of these blooms

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Genome-wide association studies (GWAS) have identified numerous common prostate cancer (PrCa) susceptibility loci. We have fine-mapped 64 GWAS regions known at the conclusion of the iCOGS study using large-scale genotyping and imputation in 25 723 PrCa cases and 26 274 controls of European ancestry. We detected evidence for multiple independent signals at 16 regions, 12 of which contained additional newly identified significant associations. A single signal comprising a spectrum of correlated variation was observed at 39 regions; 35 of which are now described by a novel more significantly associated lead SNP, while the originally reported variant remained as the lead SNP only in 4 regions. We also confirmed two association signals in Europeans that had been previously reported only in East-Asian GWAS. Based on statistical evidence and linkage disequilibrium (LD) structure, we have curated and narrowed down the list of the most likely candidate causal variants for each region. Functional annotation using data from ENCODE filtered for PrCa cell lines and eQTL analysis demonstrated significant enrichment for overlap with bio-features within this set. By incorporating the novel risk variants identified here alongside the refined data for existing association signals, we estimate that these loci now explain ∼38.9% of the familial relative risk of PrCa, an 8.9% improvement over the previously reported GWAS tag SNPs. This suggests that a significant fraction of the heritability of PrCa may have been hidden during the discovery phase of GWAS, in particular due to the presence of multiple independent signals within the same regio

Influence of ocean–atmospheric oscillations on lake ice phenology in eastern North America

Our results reveal long-term trends in ice out dates (1836–2013) for twelve lakes in Maine, New Brunswick and New Hampshire, in eastern North America. The trends are remarkably coherent between lakes (rs = 0.462–0.933, p < 0.01) and correlate closely with the March–April (MA) instrumental temperature records from the region (rs = 0.488–0.816, p < 0.01). This correlation permits use of ice out dates as a proxy to extend the shorter MA instrumental record (1876–2013). Mean ice out dates trended progressively earlier during the recovery from the Little Ice Age through to the 1940s, and gradually became later again through to the late 1970s, when ice out dates had returned to values more typical of the late nineteenth century. Post-1970’s ice out dates resumed trending toward earlier dates, with the twenty-first century being characterized by the earliest ice out dates on record. Spectral and wavelet time series analysis indicate that ice out is influenced by several teleconnections including the Quasi-biennial Oscillation, El Niño-Southern Oscillation, North Atlantic Oscillation, as well as a significant correlation between inland lake records and the Atlantic Multidecadal Oscillation. The relative influence of these teleconnections is variable with notable shifts occurring after ~1870, ~1925, and ~1980–2000. The intermittent expression of these cycles in the ice out and MA instrumental record is not only influenced by absolute changes in the intensity of the various teleconnections and other climate drivers, but through phase interference between teleconnections, which periodically damps the various signals

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049